Skip to main navigation
Skip to search
Skip to main content
Fox Chase Cancer Center Home
Help & FAQ
Link opens in a new tab
Search content at Fox Chase Cancer Center
Home
Profiles
Research Units
Research Resources
Research Outputs
Prizes
Activities
Press/Media
Tamoxifen in Ductal Carcinoma In Situ
Mary B. Daly
Cancer Prevention and Control (CPC)
Clinical Genetics
Research output
:
Contribution to journal
›
Article
›
peer-review
19
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Tamoxifen in Ductal Carcinoma In Situ'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Adoption
14%
Adverse Event
14%
Breast
28%
Breast Cancer
71%
Cancer Diagnosis
14%
Contralateral
14%
Disease
28%
Endometrial Cancer
14%
Estrogen Receptor
28%
Experience
14%
Follow up
14%
Incidence
42%
Intraductal Carcinoma
100%
Lumpectomy
14%
Mammography
14%
Neoplasm
14%
Placebo
14%
Quadrantectomy
28%
Radiation Therapy
14%
Recognition
14%
Recurrent Disease
28%
Screening
14%
Tamoxifen
100%
Therapeutic Procedure
28%
Thromboembolism
14%
Woman
100%